Dietary glucosinolates derived isothiocyanates: chemical properties, metabolism and their potential in prevention of Alzheimer's disease

Alzheimer's disease (AD) is the most prevalent form of dementia affecting millions of people worldwide. It is a progressive, irreversible, and incurable neurodegenerative disorder that disrupts the synaptic communication between millions of neurons, resulting in neuronal death and functional lo...

Full description

Saved in:
Bibliographic Details
Main Authors: Farhana Khan (Author), Abhishek Joshi (Author), Hari Prasad Devkota (Author), Vetriselvan Subramaniyan (Author), Vinoth Kumarasamy (Author), Jaya Arora (Author)
Format: Book
Published: Frontiers Media S.A., 2023-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_c1d0c8a528b043b4a84244f9aedde8a3
042 |a dc 
100 1 0 |a Farhana Khan  |e author 
700 1 0 |a Abhishek Joshi  |e author 
700 1 0 |a Hari Prasad Devkota  |e author 
700 1 0 |a Vetriselvan Subramaniyan  |e author 
700 1 0 |a Vinoth Kumarasamy  |e author 
700 1 0 |a Jaya Arora  |e author 
245 0 0 |a Dietary glucosinolates derived isothiocyanates: chemical properties, metabolism and their potential in prevention of Alzheimer's disease 
260 |b Frontiers Media S.A.,   |c 2023-07-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2023.1214881 
520 |a Alzheimer's disease (AD) is the most prevalent form of dementia affecting millions of people worldwide. It is a progressive, irreversible, and incurable neurodegenerative disorder that disrupts the synaptic communication between millions of neurons, resulting in neuronal death and functional loss due to the abnormal accumulation of two naturally occurring proteins, amyloid β (Aβ) and tau. According to the 2018 World Alzheimer's Report, there is no single case of an Alzheimer's survivor; even 1 in 3 people die from Alzheimer's disease, and it is a growing epidemic across the globe fruits and vegetables rich in glucosinolates (GLCs), the precursors of isothiocyanates (ITCs), have long been known for their pharmacological properties and recently attracted increased interest for the possible prevention and treatment of neurodegenerative diseases. Epidemiological evidence from systematic research findings and clinical trials suggests that nutritional and functional dietary isothiocyanates interfere with the molecular cascades of Alzheimer's disease pathogenesis and prevent neurons from functional loss. The aim of this review is to explore the role of glucosinolates derived isothiocyanates in various molecular mechanisms involved in the progression of Alzheimer's disease and their potential in the prevention and treatment of Alzheimer's disease. It also covers the chemical diversity of isothiocyanates and their detailed mechanisms of action as reported by various in vitro and in vivo studies. Further clinical studies are necessary to evaluate their pharmacokinetic parameters and effectiveness in humans. 
546 |a EN 
690 |a Alzheimer's disease 
690 |a isothiocyanates 
690 |a amyloid β 
690 |a phosphorylated tau 
690 |a glucosinolates 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 14 (2023) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fphar.2023.1214881/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/c1d0c8a528b043b4a84244f9aedde8a3  |z Connect to this object online.